Involvement of the renal kallikrein-kinin system in K+-induced diuresis and natriuresis in anesthetized rats

Tatsunori Suzuki, Makoto Katori, Tomoe Fujita, Yuji Kumagai, Masataka Majima

Research output: Contribution to journalArticlepeer-review

21 Citations (Scopus)

Abstract

Intravenous infusion of a high-K+ solution (67.5 mM KCl, 67.5 mM NaCl) to anesthetized rats increased urine volume by 47.6% after 60 min, compared with infusion of a Na+ solution (135 mM NaCl). This treatment also increased urinary excretion of Na+ by 32.2%, in parallel with an increase in excretion of K+ or Cl-. Urinary excretion of kallikrein increased within 60 min after the start of K+ infusion. A bradykinin B2 receptor antagonist, 8-[3-[N-[(E)-3-(6-acetamidopyridin-3-yl)acryloylglycyl]-N-methylamino]-2,6-dichlorobenzyloxy]-2-methylquinoline (FR173657; 1.0 mg/kg, i.v.), inhibited the K+-induced diuresis and natriuresis by 41.0% and 26.7%, respectively. These results indicate that K+ load induces diuresis and natriuresis through the renal kallikrein-kinin system in rats. Copyright (C) 2000 Elsevier Science B.V.

Original languageEnglish
Pages (from-to)223-227
Number of pages5
JournalEuropean Journal of Pharmacology
Volume399
Issue number2-3
DOIs
Publication statusPublished - 7 Jul 2000

Keywords

  • Bradykinin B receptor antagonist
  • Diuresis
  • FR173657
  • K
  • Kallikrein secretion
  • Natriuresis

Fingerprint

Dive into the research topics of 'Involvement of the renal kallikrein-kinin system in K+-induced diuresis and natriuresis in anesthetized rats'. Together they form a unique fingerprint.

Cite this